Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Neurology
Published in: Journal of Neurology 12/2010

01-12-2010 | Letter to the Editors

Amyloid myopathy: a therapeutic trial for the rare and underdiagnosed myopathy with bortezomib

Authors: Kensuke Shiga, Reiko Mizutani, Reina Isayama, Chihiro Shimazaki, Takahiko Tokuda, Masanori Nakagawa

Published in: Journal of Neurology | Issue 12/2010

Login to get access

Excerpt

Dear Sirs, …
Literature
1.
Prayson RA (1998) Amyloid myopathy: clinicopathological study of 16 cases. Human Pathol 29:463–468CrossRef
2.
Gertz MA, Kyle RA (1996) Myopathy in primary systemic amyloidosis. J Neurol Neurosurg Psychiatry 60:655–660CrossRefPubMed
3.
Chapin JE, Kornfeld M, Harris A (2005) Amyloid myopathy: characteristic features of a still underdiagnosed disease. Muscle Nerve 31:266–272CrossRefPubMed
4.
Spuler S, Emslie-Smith A, Engel AG (1998) Amyloid myopathy: an underdiagnosed entity. Ann Neurol 43:719–728CrossRefPubMed
5.
Doriguzzi C, Mongini T, Troni W, Monga G (1987) Early sarcolemmal dysfunction in skeletal muscle amyloidosis. J Neurol 234:52–54CrossRefPubMed
6.
Richardson PG, Barloqie B, Berenson J, Singhal S, Jagannath S, Irwin D et al (2003) A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med 348:2609–2617CrossRefPubMed
7.
Kastritis E, Wechalekar AD, Dimopoulos MA, Merlini G, Hawkins PN, Perfetti V, Gillmore JD, Palladini G (2010) Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosis. J Clin Oncol 28:1031–1037CrossRefPubMed
8.
Metadata
Title
Amyloid myopathy: a therapeutic trial for the rare and underdiagnosed myopathy with bortezomib
Authors
Kensuke Shiga
Reiko Mizutani
Reina Isayama
Chihiro Shimazaki
Takahiko Tokuda
Masanori Nakagawa
Publication date
01-12-2010
Publisher
Springer-Verlag
Published in
Journal of Neurology / Issue 12/2010
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-010-5642-0

Other articles of this Issue 12/2010

Journal of Neurology 12/2010 Go to the issue

Original Communication

Late-onset Leber hereditary optic neuropathy mimicking Susac’s syndrome

Original Communication

The new Alzheimer’s criteria in a naturalistic series of patients with mild cognitive impairment

Letter to the Editors

Severe encephalopathy and polyneuropathy induced by dichloroacetate

Medical Progress in the Journal of Neurology

Neuromuscular disorders and 2010: recent advances

Original Communication

Cerebral infarction in acute anemia

Original Communication

CHMP2B mutations are rare in French families with frontotemporal lobar degeneration